Clinical Trials Browser

Phase 1 × relacorilant × 30 days × Clear all

NCT03674814 2026-03-04

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

Phase 1 Active not recruiting

Prostatic Neoplasms